Back to HighTower Advisors, LLC HighTower Advisors, LLC

TGTXTGTX

Showing 8 of 31 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in TG Therapeutics, Inc.

Yes. HighTower Advisors holds 20,250 shares of TGTX (TG Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It reduced the position by 5,023 shares (-19.9%) from Q1 2026. HighTower Advisors has held TGTX in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$1.1M

Current Shares

20,250

Total Value Change

+$818,535

Total Shares Change

+7,724

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
20,250
-19.9%
$1.1M0.0%$54.94
0
2026-Q1
Increased
25,273
+8.6%
$839,5690.0%$33.22
27
2025-Q4
Decreased
23,282
-16.2%
$694,0360.0%$29.81
0
2025-Q3
Increased
27,793
+17.5%
$1M0.0%$36.13
29
2025-Q2
Increased
23,650
+3.3%
$851,1750.0%$35.99
26
2025-Q1
Increased
22,891
+53.5%
$902,5930.0%$39.43
35
2024-Q4
Increased
14,912
+19.1%
$448,8510.0%$30.10
28
2024-Q3
Increased
12,526
+19.6%
$294,0000.0%$23.39
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used